Swarup Swaminathan, MD
Enriched profileAssociate Professor of Clinical Ophthalmology; Mary Lee and Richard E. Bastin Chair in Ophthalmology · Bascom Palmer Eye Institute
Swarup Swaminathan is Associate Professor of Clinical Ophthalmology; Mary Lee and Richard E. Bastin Chair in Ophthalmology at Bascom Palmer Eye Institute. OpenAlex indexes 98 publications with 1,536 citations (h-index 19); ClinicalTrials.gov lists 1 registered study with this person as an investigator.
Data verified 18 Oct 2026
Overview
Updated 18 Oct 2026
Swarup Swaminathan, MD, is Associate Professor of Clinical Ophthalmology at Bascom Palmer Eye Institute, University of Miami Miller School of Medicine. The public record shows 98 publications with 1,536 citations (h-index 19), centered on Glaucoma and retinal disorders, Corneal surgery and disorders, Retinal Diseases and Treatments. It also documents an investigator role on 1 registered clinical trials, industry payments reported by 14 companies, 1 NIH-funded awards (2022–2026).
- Most recent indexed publication: 2026 · medRxiv
- Top research focus: Glaucoma and retinal disorders
- 1 registered trials on ClinicalTrials.gov
- Open Payments reporting from 14 companies
Generated from the cited public record · current as of 18 Oct 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 8 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 34.
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 18 Oct 2026
Listed as an investigator on 1 registered study on ClinicalTrials.gov. The most recent:
- Biomarkers of Ocular Surface Damage in the Setting of Topical Ocular Hypotensive Medication Use
Sponsor: University of Miami
Industry payments
Updated 18 Oct 2026
14 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- ABBVIE INC.Program year202512 payments$16,733openpaymentsdata.cms.gov ↗
- Glaukos CorporationProgram year20252 payments
- ABBVIE INC.Program year20243 payments
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Sensory organs
89.8%Prostaglandin Analog35.2%Latanoprost84%Lumigan12%Travoprost4%Part D<11 patientsCarbonic Anhydrase Inhibitor22.3%Dorzolamide-Timolol74%Dorzolamide Hcl19%Acetazolamide4%Brinzolamide3%Part D<11 patients+ 5 more classes in this area
Cardiovascular
7.7%Beta blocker7.7%Timolol Maleate100%Part D≥52 patientsMusculoskeletal
1.2%Cyclooxygenase Inhibitor1.2%Ketorolac Tromethamine100%Part D≥22 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
Updated 18 Oct 2026
1 NIH research award on record, funded 2022–2026 per NIH RePORTER. The latest:
- Improving Individualized Assessments of Glaucoma Progression with Population-Based Electronic Health Record Data
University of Miami School of Medicine
FY2026$206,727K23EY033831 - Improving Individualized Assessments of Glaucoma Progression with Population-Based Electronic Health Record Data
University of Miami School of Medicine
FY2025$210,027K23EY033831 - Improving Individualized Assessments of Glaucoma Progression with Population-Based Electronic Health Record Data
University of Miami School of Medicine
FY2024$206,091K23EY033831
Publications
Updated 18 Oct 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Improved Estimation of Rates of Glaucoma Progression Using Spatial Two-Fold Linear Mixed Models.
Journal of statistical theory and applications
Article2026
Most-cited works
by citation count (OpenAlex)- 01The structural basis of cyclic diguanylate signal transduction by PilZ domainsArticle227 citations2007
- 02
- 03Semaglutide and Nonarteritic Anterior Ischemic Optic NeuropathyArticle118 citations2025
- 04Secreted Protein Acidic and Rich in Cysteine (SPARC)-Null Mice Exhibit More Uniform OutflowArticle101 citations2013
- 05Aqueous outflow: Segmental and distal flowArticle90 citations2014
Network
Updated 18 Oct 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Online presence
Updated 18 Oct 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accounts
public accounts run by this person- Doximity
doximity.com/pub/swarup-swaminathan-md
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗
Mentions by others
where others cite or feature them- Other
ophthalmology360.com/advisoryboard/swarup-swaminathan
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →ophthalmology360.com ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 18 Oct 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- MD
Harvard Medical School
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →med.miami.edu ↗ - BA
Columbia University
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →med.miami.edu ↗
Editorial & leadership roles
journal and society appointments- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →ophthalmology360.com ↗
Awards & honors
honors on the public record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →med.miami.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →med.miami.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →ophthalmology360.com ↗
Secondary affiliations
appointments beyond the home institution- Medical Director for Informatics
Bascom Palmer Eye Institute
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →ophthalmology360.com ↗ - Secondary appointment
Department of Public Health Sciences, University of Miami
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →ophthalmology360.com ↗
Media & interviews
press, podcasts and appearances- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →managedhealthcareexecutive.com ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Steven Gedde, MD
Bascom Palmer Eye Institute
Richard Parrish, MD
Bascom Palmer Eye Institute
Thomas Albini, MD
Bascom Palmer Eye Institute
Emily Chew, MD
National Eye Institute
Robert Weinreb, MD
University of California San Diego
Harry Quigley, MD
Johns Hopkins University School of Medicine
Joel Schuman, MD
Wills Eye Hospital